PRKN and Parkinson disease: Successful treatment of juvenile PD with bilateral STN-DBS in a 14-year-old pediatric PD patient with parkin mutation has also been reported, suggesting the possible effectiveness of DBS in the pediatric population with parkin mutations [57].